- Home
- GHRS vs PFLT Comparison
GHRS vs PFLT Comparison
Compare GHRS & PFLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | PFLT |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 947.2M | 805.6M |
| IPO Year | 2021 | 2010 |
Fundamental Metrics
Financial Performance| Metric | GHRS | PFLT |
|---|---|---|
| Price | $20.58 | $9.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $41.38 | $10.50 |
| AVG Volume (30 Days) | 233.9K | ★ 887.8K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 14.12% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.16 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $24.14 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.52 | $7.68 |
| 52 Week High | $24.66 | $10.88 |
Technical Indicators
Market Signals| Indicator | GHRS | PFLT |
|---|---|---|
| Relative Strength Index (RSI) | 65.41 | 66.07 |
| Support Level | $12.54 | $8.93 |
| Resistance Level | $24.66 | $9.46 |
| Average True Range (ATR) | 1.62 | 0.18 |
| MACD | 0.16 | 0.03 |
| Stochastic Oscillator | 50.55 | 89.84 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About PFLT PennantPark Floating Rate Capital Ltd.
PennantPark Floating Rate Capital Ltd is a closed-end, externally managed, non-diversified investment company. Its investment objectives are to generate both current income and capital appreciation by investing in Floating Rate Loans and other investments made to U.S. middle-market companies. The company believes that Floating Rate Loans to U.S. middle-market companies offer attractive risk-reward to investors due to the limited amount of capital available for such companies and the potential for rising interest rates. The company generates revenue in the form of interest income on the debt securities and dividends.